NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 118 filers reported holding NUVALENT INC in Q3 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,975,356 | -6.2% | 1,239,403 | -14.0% | 0.74% | -3.4% |
| Q2 2023 | $60,755,584 | +66.0% | 1,440,730 | +2.7% | 0.77% | +49.2% |
| Q1 2023 | $36,591,877 | -26.6% | 1,402,525 | -16.2% | 0.51% | -30.8% |
| Q4 2022 | $49,828,313 | +62.6% | 1,673,214 | +6.1% | 0.74% | +60.1% |
| Q3 2022 | $30,644,000 | +61.1% | 1,576,326 | +12.4% | 0.46% | +50.6% |
| Q2 2022 | $19,017,000 | +18.0% | 1,402,451 | +20.9% | 0.31% | +55.6% |
| Q1 2022 | $16,113,000 | -28.3% | 1,160,068 | -1.7% | 0.20% | -13.5% |
| Q4 2021 | $22,480,000 | -5.3% | 1,180,696 | +12.2% | 0.23% | -18.5% |
| Q3 2021 | $23,731,000 | – | 1,052,394 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $918,987,373 | 20.25% |
| Bain Capital Life Sciences Investors, LLC | 3,577,267 | $164,446,964 | 18.39% |
| Fairmount Funds Management LLC | 2,451,819 | $112,710,119 | 13.56% |
| Paradigm Biocapital Advisors LP | 1,638,147 | $75,305,618 | 5.11% |
| COMMODORE CAPITAL LP | 828,778 | $38,098,925 | 4.45% |
| Perceptive Advisors | 2,463,451 | $113,244,842 | 3.78% |
| Boxer Capital, LLC | 1,210,192 | $55,632,526 | 2.96% |
| Tri Locum Partners LP | 113,528 | $5,218,882 | 1.67% |
| Ikarian Capital, LLC | 278,034 | $12,781,224 | 1.54% |
| Ikarian Capital, LLC | 2,395 | $11,009,815 | 1.32% |